A randomized double-blind placebo-controlled trial of low-dose interleukin-2 in relapsing–remitting multiple sclerosis

被引：0
|
作者：
C. Louapre
M. Rosenzwajg
M. Golse
A. Roux
F. Pitoiset
L. Adda
N. Tchitchek
C. Papeix
E. Maillart
A. Ungureanu
F. Charbonnier-Beaupel
D. Galanaud
J. C. Corvol
E. Vicaut
C. Lubetzki
D. Klatzmann
机构：
[1] Sorbonne University,Neuroradiology Department
[2] Paris Brain Institute - ICM,undefined
[3] Assistance Publique Hôpitaux de Paris,undefined
[4] Inserm,undefined
[5] CNRS,undefined
[6] Hôpital de la Pitié Salpêtrière,undefined
[7] Department of Neurology,undefined
[8] CIC neurosciences,undefined
[9] Immunology-Immunopathology-Immunotherapy (i3)-UMRS_959,undefined
[10] Sorbonne Université- INSERM,undefined
[11] Assistance Publique Hôpitaux de Paris,undefined
[12] Hôpital Pitié-Salpêtrière,undefined
[13] Clinical Investigation Center for Biotherapies (CIC-BTi) and Immunology-Inflammation-Infectiology and Dermatology Department (3iD),undefined
[14] Assistance Publique Hôpitaux de Paris,undefined
[15] Hôpital Pitié-Salpêtrière,undefined
[16] Pharmacie à Usage Intérieur,undefined
[17] Reqpharm Unit,undefined
[18] Sorbonne University,undefined
[19] Assistance Publique Hôpitaux de Paris,undefined
[20] Assistance Publique Hôpitaux de Paris,undefined
[21] Lariboisière Hospital,undefined
[22] Clinical Trial Unit,undefined
来源：
Journal of Neurology | 2023年 / 270卷
关键词：
Neuroinflammation; Neurodegeneration; Immunoregulation; Immunosuppression; Tolerance; Immunotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：4403 / 4414
页数：11
相关论文
共 50 条
  • [1] A randomized double-blind placebo-controlled trial of low-dose interleukin-2 in relapsing-remitting multiple sclerosis
    Louapre, C.
    Rosenzwajg, M.
    Golse, M.
    Roux, A.
    Pitoiset, F.
    Adda, L.
    Tchitchek, N.
    Papeix, C.
    Maillart, E.
    Ungureanu, A.
    Charbonnier-Beaupel, F.
    Galanaud, D.
    Corvol, J. C.
    Vicaut, E.
    Lubetzki, C.
    Klatzmann, D.
    JOURNAL OF NEUROLOGY, 2023, 270 (09) : 4403 - 4414
  • [2] Low dose interleukin-2 in relapsing-remitting multiple sclerosis: A randomized double-blinded placebo-controlled trial
    Louapre, C.
    Rosenzwag, M.
    Golse, M.
    Galanaud, D.
    Papeix, C.
    Maillart, E.
    Ungureanu, A.
    Corvol, J. -C.
    Vicaut, E.
    Lubetzki, C.
    Klatzmann, D.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 550 - 551
  • [3] A double-blind, placebo-controlled, randomized trial of cladribine in relapsing-remitting multiple sclerosis
    Romine, JS
    Sipe, JC
    Koziol, JA
    Zyroff, J
    Beutler, E
    PROCEEDINGS OF THE ASSOCIATION OF AMERICAN PHYSICIANS, 1999, 111 (01) : 35 - 44
  • [4] Firategrast for relapsing remitting multiple sclerosis: a phase 2, randomised, double-blind, placebo-controlled trial
    Miller, David H.
    Weber, Thomas
    Grove, Richard
    Wardell, Claire
    Horrigan, Joseph
    Graff, Ole
    Atkinson, Gillian
    Dua, Pinky
    Yousry, Tarek
    MacManus, David
    Montalban, Xavier
    LANCET NEUROLOGY, 2012, 11 (02): : 131 - 139
  • [5] Probiotic supplementation and systemic inflammation in relapsing-remitting multiple sclerosis: A randomized, double-blind, placebo-controlled trial
    Rahimlou, Mehran
    Nematollahi, Shima
    Husain, Durdana
    Banaei-Jahromi, Nasrin
    Majdinasab, Nastaran
    Hosseini, Seyed Ahmad
    FRONTIERS IN NEUROSCIENCE, 2022, 16
  • [6] Acyclovir treatment of relapsing-remitting multiple sclerosis - A randomized, placebo-controlled, double-blind study
    Lycke, J
    Svennerholm, B
    Hjelmquist, E
    Frisen, L
    Badr, G
    Andersson, M
    Vahlne, A
    Andersen, O
    JOURNAL OF NEUROLOGY, 1996, 243 (03) : 214 - 224
  • [7] Low-dose interleukin-2 in patients with bipolar depression: A phase 2 randomised double-blind placebo-controlled trial
    Leboyer, Marion
    Foiselle, Marianne
    Tchitchek, Nicolas
    Tamouza, Ryad
    Lorenzon, Roberta
    Richard, Jean-Romain
    Arrouasse, Raphaele
    Le Corvoisier, Philippe
    Le Dudal, Katia
    Vicaut, Eric
    Ellul, Pierre
    Rosenzwajg, Michelle
    Klatzmann, David
    BRAIN BEHAVIOR AND IMMUNITY, 2025, 123 : 177 - 184
  • [8] A placebo-controlled, randomized, double-blind, MRI trial of antiherpes therapy in patients with relapsing-remitting multiple sclerosis (RRMS)
    Jakobsen, J
    Bech, E
    Gadeberg, P
    Hansen, HJ
    Christensen, T
    Haahr, S
    Hollsberg, P
    Lycke, J
    Malmestrom, C
    Ekholm, S
    Bergstrom, T
    Svennerholm, B
    Andersen, O
    NEUROLOGY, 2001, 56 (08) : A74 - A74
  • [9] High dose Vitamin D intake and quality of life in relapsing-remitting multiple sclerosis: a randomized, double-blind, placebo-controlled clinical trial
    Ashtari, Fereshteh
    Toghianifar, Nafiseh
    Zarkesh-Esfahani, Sayyed Hamid
    Mansourian, Marjan
    NEUROLOGICAL RESEARCH, 2016, 38 (10) : 888 - 892
  • [10] Low-dose topiramate in alcohol dependence: a randomized, double-blind, placebo-controlled trial
    Hatzigiakoumis, D. S.
    Martinotti, G.
    De Vita, O.
    Di Nicola, M.
    Gualtieri, I.
    Tedeschi, D.
    Guglielmo, R.
    Quatrale, M.
    Pozzi, G.
    Janiri, L.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2012, 22 : S391 - S391
12345